Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: Hong Kong Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20094
20113
20143
20153
20181
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated4
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Bayer2
Boehringer Ingelheim2
Chinese University of Hong Kong2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Puma Biotechnology, Inc.2
ASLAN Pharmaceuticals1
Genentech, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms19
Neoplasm Metastasis2
Brain Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Cholangiocarcinoma1
Colorectal Neoplasms1
Head and Neck Neoplasms1
Inflammatory Breast Neoplasms1
Lymphoma, Large-Cell, Anaplastic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.